Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes

BioFactors

Volumn 38, Issue 1, 2012, Pages 59-68

  Sundaram, Bhuvaneshwari ^a   Singhal, Kirti ^a   Sandhir, Rajat ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Chromium; Diabetes; Glucose; Liver; Metabolism

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CHROMIUM PICOLINATE; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVATE KINASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BULIMIA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; LIVER METABOLISM; MALE; NONHUMAN; POLYDIPSIA; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

ADULT; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCONEOGENESIS; GLUCOSE; GLYCOGEN; GLYCOLYSIS; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; MALE; MIDDLE AGED; PICOLINIC ACIDS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STREPTOZOCIN;

ANIMALIA; RATTUS;

EID: 84857654134     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.194     Document Type: Article

References (96)

1. King, H., Aubert, R. E., and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431.
2. Perry, I. J. (2001) Commentary: smoking and diabetes-accumulating evidence of a causal link. Int. J. Epidemiol. 30, 554-555.
3. Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., and Uusitupa, M. (2001) Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343-1350.
4. Vallis, M., Ruggiero, L., Greene, G., Jones, H., Zinman, B., Rossi, S., Edwards, L., Rossi, J. S., and Prochaska, J. O. (2003) Stages of change for healthy eating in diabetes: relation to demographic, eating-related, health care utilization, and psychosocial factors. Diabetes Care 26, 1468-1474.
5. Stafylas, P. C., Sarafidis, P. A., and Lasaridis, A. N. (2009) The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality. Int. J. Cardiol. 131, 298-304.
6. Hadrzynski, C. (1999) Diabetes and trace elements. J. Trace Elem. Exp. Med. 12, 367-374.
7. Narendhirakannan, R. T., Subramanian, S., and Kandaswamy, M. (2005) Mineral content of some medicinal plants used in the treatment of diabetes mellitus. Biol. Trace Elem. Res. 103, 109-116.
8. Zhang, L., Zhang, Y., Xia, Q., Zhao, X. M., Cai, H. X., Li, D. W., Yang, X. D., Wang, K., and Xia, Z. L. (2008) Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction. Food Chem. Toxicol. 46, 2996-3002.
9. Wijesekara, N., Chimienti, F., and Wheeler, M. B. (2009) Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes. Metab. 4, 202-214.
10. Anderson, R. A. (1999) Chromium and diabetes. Nutrition 15, 720-722.
11. Shinde, U. A., Sharma, G., Xu, Y. J., Dhalla, N. S., and Goyal, R. K. (2004) Anti-diabetic activity and mechanism of action of chromium chloride. Exp. Clin. Endocrinol. Diabetes. 112, 248-252.
12. Ravina, A., Slezak, L., Rubal, A., and Mirsky, N. (1995) Clinical use of the trace element chromium(III) in the treatment of diabetes mellitus. J. Trace Elem. Exp. Med. 8, 183-190.
13. Cefalu, W. T. and Hu, F. B. (2004) Role of chromium in human health and in diabetes. Diabetes Care 27, 2741-2751.
14. Anderson, R. A. (1995) Chromium and parenteral nutrition. Nutrition 11, 83-86.
15. Martin, J., Matthews, D. E., and Wang, Z. (2005) Effect of chromium picolinate on body composition, insulin sensitivity, and glycemic control in subjects with type 2 diabetes. Diabetes 54, A427.
16. Anderson, R. A. (1998) Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17, 548-555.
17. Rabinowitz, H., Friedensohn, A., Leibovitz, A., Gabay, G., Rocas, C., and Habot, B. (2004) Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int. J. Vitam. Nutr. Res. 74, 178-182.
18. Król, E. and Krejpcio, Z. (2010) Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem. Toxicol. 48, 2791-2796.
19. Sahin, K., Onderci, M., Tuzcu, M., Ustundag, B., Cikime, G., Ozercanf, I. H., Sriramojug, V., Juturuh, V., and Komorowskih, J. R. (2007) Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed streptozotocin-treated rat. Metabolism 56, 1233-1240.
20. Vincent, J. B. (2000) Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr. Rev. 58, 67-72.
21. Anderson, R. A. (1997) Nutritional factors influencing the glucose/insulin system: chromium. J. Am. Coll. Nutr. 16, 404-410.
22. Sreekanth, R., Pattabhi, V., and Rajan, S. S. (2008) Molecular basis of chromium insulin interactions. Biochem. Biophys. Res. Commun. 369, 725-729.
23. Pilkis, S. J. and Granner, D. K. (1992) Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 54, 885-909.
24. Evans, G. W. and Pouchnik, D. J. (1993) Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 49, 177-187.
25. Preuss, H. G., Echard, B., Perricone, N. V., Bagchi, D., Yasmi, T., and Stohs, S. J. (2008) Comparing metabolic effects of six different commercial trivalent chromium compounds. J. Inorg. Biochem. 102, 1986-1990.
26. Stearns, D. M. and Armstrong, W. H. (1992) Mononuclear and binuclear chromium(III) picolinate complexes. Inorg. Chem. 31, 6178-6184.
27. Lamson, D. W. and Plaza, S. M. (2002) The safety and efficacy of high-dose chromium. Altern. Med. Rev. 7, 218-235.
28. Abdourahman, A. and Edwards, J. G. (2008) Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizaki rats. IUBMB Life 60, 541-548.
29. Hujing, F. (1970) A rapid enzymatic method for glycogen determination in a very small tissue samples. Clin. Chem. Acta. 30, 567-572.
30. Pilks, S. J. (1975) Glucokinase in rat liver. In Methods of Enzymology. (Colowick, S. P. and Kaplan, N. O., eds.). pp. 31-39, Academic Press, New York.
31. Davidson, A. V. and Arion, W. J. (1987) Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch. Biochem. Biophys. 253, 156-167.
32. Bartrons, J. E., Hue, L., and Hers, H. G. (1977) Assay of kinase. Eur. J. Biochem. 81, 609-617.
33. Valentine, W. N. and Tanaka, K. R. (1966) Pyruvate kinase: Clinical aspects. In Methods of Enzymology: Carbohydrate Metabolism. (Wood, W. A., ed.). pp. 468-473, Academic Press, New York.
34. Harper, A. E. (1970) Glucose-6-phosphatase. In Methods of Enzymatic Analysis. (Bergmeyer, H. U., ed.). pp. 788-793, Academic Press, New York.
35. Fiske, C. H. and Subbarow, Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem. 66, 375-400.
36. Opie, L. H. and Newholmie, E. A. (1967) The activities of fructose 1, 6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem. J. 108, 391-399.
37. 14C)-deoxy-D-glucose and translocation of glucose transport to membrane fraction in rat adipocytes. J. Auton. Nerv. Syst. 61, 191-194.
38. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275.
39. Evenson, M. A. and Anderson, C. T. (1975) Ultramicroanalysis for copper, cadmium and zinc in human liver tissues by the use of atomic absorption spectrophotometry. Clin. Chem. 21, 537-543.
40. Ziel, E. H., Venkatesan, N., and Davidson, M. B. (1988) Glucose transport is rate limiting for skeleton muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37, 885-889.
41. Rossetti, L., Giaccari, A., and DeFronzo, R. A. (1990) Glucose toxicity. Diabetes Care 13, 610-630.
42. Robertson, R. P., Olson, L. K., and Zhang, H. J. (1994) Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 9, 1085-1089.
43. Cefalu, W. T., Wang, Z. Q., Zhang, X. H., Baldor, L. C., and Russell, J. C. (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J. Nutr. 32, 1107-1114.
44. Martin, J., Wang, Z. Q., Zhang, X. H., Wachtel, D., Volaufova, J., Matthews, D. E., and Cefalu, W. T. (2006) Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29, 1826-1832.
45. Kim, D. S., Kim, T. W., and Kang, J. S. (2004) Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J. Trace Elem. Med. Biol. 17, 243-247.
46. Wang, Z. Q. and Cefalu, W. T. (2010) Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Curr. Diab Rep. 10, 145-151.
47. Pattar, G. R., Tackett, L., Liu, P., and Elmendorf, J. S. (2006) Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat. Res. 610, 93-100.
48. Lai, M. H., Chen, Y. Y., and Cheng, H. H. (2006) Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats. Int. J. Vitam. Nutr. Res. 76, 391-397.
49. Anderson, R. A. (2000) Chromium in the prevention and control of diabetes. Diabetes Metab. 26, 22-27.
50. Vincent, J. B. (2000) The biochemistry of chromium. J. Nutr. 130, 715-718.
51. Wang, H., Kruszewski, A., and Brautigan, D. L. (2005) Cellular chromium enhances activation of insulin receptor kinase. Biochemistry 44, 8167-8175.
52. Campbell, W. W., Polansky, M. M., Bryden, N. A., Soares, J. H., Jr., and Anderson, R. A. (1989) Exercise training and dietary chromium effects on glycogen, glycogen synthase, phosphorylase and total protein in rats. J. Nutr. 119, 653-660.
53. Wu, X. Y., Li, F., Xu, W. D., Zhao, J. L., Zhao, T., Liang, L. H., and Yang, L. Q. (2010) Anti-hyperglycemic activity of chromium(III) malate complex in alloxan-induced diabetic rats. Biol. Trace Elem. Res. 143, 1031-1043.
54. Qiao, W., Peng, Z., Wang, Z., Wei, J., and Zhou, A. (2009) Chromium improves glucose uptake and metabolism through upregulating the mRNA levels of IR, GLUT4, GS, and UCP3 in skeletal muscle cells. Biol. Trace Elem. Res. 131, 133-142.
55. Ilouz, R., Kaidanovich, O., Gurwitz, D., and Eldar-Finkelman, H. (2002) Inhibition of glycogen synthase kinase-3b by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem. Biophys. Res. Commun. 295, 102-106.
56. Semiz, S. and McNeill, J. H. (2002) Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity. Mol. Cell. Biochem. 236, 123-131.
57. Seoane, J., Barbera, A., Télémaque-Potts, S., Newgard, C. B., and Guinovart, J. J. (1999) Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J. Biol. Chem. 274, 31833-31838.
58. Agius, L., Peak, M., Newgard, C. B., Gomez-Foix, A. M., and Guinovart, J. J. (1996) Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. J. Biol. Chem. 271, 30479-30486.
59. Dong, F., Kandadi, M. R., Ren, J., and Sreejayan, N. (2008) Chromium (D-phenylalanine)3 supplementation alters glucose disposal, insulin signaling, and glucose transporter-4 membrane translocation in insulin-resistant mice. J. Nutr. 138, 1846-1851.
60. Davis, C. M., Sumrall, K. H., and Vincent, J. B. (1996) A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35, 12963-12969.
61. Davis, C. M. and Vincent, J. B. (1997) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36, 4382-4385.
62. Chen, W. Y., Chen, C. J., Liu, C. H., and Mao, F. C. (2009) Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes. Metab. 11, 293-303.
63. Miranda, E. R. and Dey, C. S. (2004) Effect of chromium and zinc on insulin signaling in skeletal muscle cells. Biol. Trace Elem. Res. 101, 19-36.
64. Penumathsa, S. V., Thirunavukkarasu, M., Samuel, S. M., Zhan, L., Maulik, G., Bagchi, M., Bagchi, D., and Maulik, N. (2009) Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochim. Biophys. Acta. 1792, 39-48.
65. Ferre, T., Riu, E., Bosch, F., and Valera, A. (1996) Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J. 10, 1213-1218.
66. Hariharan, N., Farrelly, D., Hagan, D., Hillyer, D., Arbeeny, C., Sabrah, T., Treloar, A., Brown, K., Kalinowski, S., and Mookhtiar, K. (1997) Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight. Diabetes 46, 11-16.
67. Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., and Magnuson, M. A. (1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305-315.
68. Matschinsky, F. M. (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 39, 647-652.
69. Sibrowski, S. and Seitz, H. J. (1984) The chemistry of chromium. J. Biol. Chem. 259, 343-346.
70. Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., Le-Liepvre, X., Berthelier-Lubrano, C., Spiegelman, B., Kim, J. B., Ferre, P., and Foufelle, F. (1999) ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19, 3760-3768.
71. Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., and Goldstein, J. L. (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induce diabetes. Proc. Natl. Acad. Sci. USA 96, 13656-13661.
72. McCarty, M. F. (1999) High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes. Med Hypotheses. 52, 401-406.
73. Smith, W., Langer, S., Wu, C., Baltrusch, S., and Okar, D. A. (2007) Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase:glucokinase complex. Mol. Endocrinol. 21, 1478-1487.
74. Lau, F. C., Bagchi, M., Sen, C. K., and Bagchi, D. (2008) Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes. Mol. Cell. Biochem. 317, 1-10.
75. Heisner, D. D., Chang, H. C., and Lane, M. D. (1985) The enzymatic carboxylation of phosphoenolpyruvate-purification and properties of liver mitochondrial phosphoenol pyruvate carboxykinase. J. Biol. Chem. 241, 2413-2420.
76. Hlavaty, J. J. and Nowak, T. (1998) Chromium (III) modification of the first metal binding site of phosphoenolpyruvate carboxykinase. Biochemistry 37, 8061-8068.
77. McCaffrey, J., Wolf, C. M., and Hamilton, J. W. (1994) Effects of the genotoxic carcinogen chromium (VI) on basal and hormone inducible phosphoenolpyruvate carboxykinase gene expression in vivo. Correlation with glucocorticoid and developmentally regulated expression. Mol. Carcinog. 10, 189-198.
78. O'Brien, R. M. and Granner, D. K. (1996) Regulation of gene expression by insulin. Physiol. Rev. 76, 1109-1161.
79. Schmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., and Unterman, T. G. (2000) Regulation of glucose-6-phosphatase gene expression by protein kinase B-alpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 275, 36324-36333.
80. Cournarie, F., Azzout-Marniche, D., Foretz, M., Guichard, C., Ferre, P., and Foufelle, F. (1999) The inhibitory effect of glucose on phosphoenolpyruvate carboxykinase gene expression in cultured hepatocytes is transcriptional and requires glucose metabolism. FEBS Lett. 460, 527-532.
81. Tuzcu, M., Sahin, N., Orhan, C., Agca, C. A., Akdemir, F., Tuzcu, Z., Komorowski, J., and Sahin, K. (2011) Impact of chromium histidinate on high fat diet induced obesity in rats. Nutr. Metab. (Lond). 8, 28.
82. Wang, Z. Q., Zhang, X. H., Russell, J. C., Hulver, M., and Cefalu, W. T. (2006) Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J. Nutr. 136, 415-420.
83. Wang, Y. and Yao, M. (2009) Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK. J. Nutr. Biochem. 20, 982-991.
84. Jain, S. K. and Kannan, K. (2001) Chromium chloride inhibits oxidative stress and TNF-alpha secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem. Biophys. Res. Commun. 289, 687-691.
85. Jain, S. K., Rains, J. L., and Croad, J. L. (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic. Biol. Med. 43, 1124-1131.
86. Jain, S. K., Rains, J. L., and Croad, J. L. (2007) High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxid Redox Signal. 9, 1581-1590.
87. Matsuoka, T. (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Investig. 99, 144-150.
88. Lelli, S. M., San, L. C., Viale, M. D., and Mazzetti, M. B. (2005) Response of glucose metabolism enzymes in an acute porphyria model role of reactive oxygen species. Toxicology 216, 49-58.
89. England, K., O'Driscoll, C., and Cotter, T. G. (2004) Carbonylation of glycolytic proteins is a key response to drug-induced oxidative stress and apoptosis. Cell Death Differ. 11, 252-260.
90. Lai, M. H. (2008) Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and E supplementation for type 2 diabetes mellitus. J. Clin. Biochem. Nutr. 43, 191-198.
91. Morris, B. W., Kemp, G. J., and Hardisty, C. A. (1985) Plasma chromium and chromium excretion in diabetes. Clin. Chem. 31, 334-335.
92. Morris, B. W., MacNeil, S., Hardisty, C. A., Heller, S., Burgin, C., and Gray, T. A. (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. J. Trace Elem. Med. Biol. 13, 57-61.
93. Rhodes, N. R., McAdory, D., Love, S., DiBona, K. R., Chen, Y., Ansorge, K., Hira, J., Kern, N., Kent, J., Lara, P., Rasco, J. F., and Vincent, J. B. (2010) Urinary chromium loss associated with diabetes is offset by increases in absorption. J. Inorg. Biochem. 104, 790-797.
94. Rhodes, M. C., Hébert, C. D., Herbert, R. A., Morinello, E. J., Roycroft, J. H., Travlos, G. S., and Abdo, K. M. (2005) Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem. Toxicol. 43, 21-29.
95. Shinde, U. A. and Goyal, R. K. (2003) Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J. Cell. Mol. Med. 7, 322-329.
96. Anderson, R. A., Bryden, N. A., and Polansky, M. M. (1997) Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16, 273-279.